Quick navigation A.K.A. Intake Synergies Conditions Functions Systems

What are Chiretta's other names?

• Andrographis paniculata
• Chuanxinlian
• Creat
• Indian Echinacea
• Kalmegh
• King of Bitters
• Lanhelian
• Yijianxi

What is Chiretta's recommended dosage?

• Recommended daily intake: 2 - 6 g

What supplements interact with Chiretta?

Chiretta and Eleuthero

1 synergy Increase of Effectiveness

What can Chiretta help with?

Chiretta for Immune System and Disorders

1 study Moderately Positive It is concluded that Andrographis paniculata had a high degree of effectiveness in reducing the prevalence and intensity of the symptoms in uncomplicated common cold beginning at day two of treatment. No adverse effects were observed or reported.

Chiretta for Tonsillitis

1 study Moderately Positive The baseline characteristics of the patients among the three groups were not different. The efficacy of paracetamol or high dose Andrographis paniculata was significantly more than that of low dose Andrographis paniculata at day 3 in terms of the relief of fever and sore throat. The clinical effects were not different at day 7. Minimal and self limiting side effects were found in about 20 per cent in each group.

Chiretta for Ulcerative Colitis

2 studies Moderately Positive HMPL-004 may be an efficacious alternative to mesalazine in ulcerative colitis. Moderately Positive Patients with mildly to moderately active ulcerative colitis treated with A. paniculata extract (HMPL-004) at a dose of 1,800 mg daily were more likely to achieve clinical response than those receiving placebo.

Chiretta for Common Cold

1 study Slightly Positive The findings of this study revealed that KalmCold was effective in reducing symptoms of upper respiratory tract infection.

Chiretta for Rheumatoid Arthritis

1 study Slightly Positive Moreover, it was associated to a reduction of rheumatoid factor, IgA, and C4. These findings suggest that A. paniculata could be a useful "natural complement" in the treatment of AR; however, a larger trial and a more extended period of treatment is necessary in order to corroborate these results.

What is Chiretta used for?

Chiretta for Digestion

2 studies Moderately Positive HMPL-004 may be an efficacious alternative to mesalazine in ulcerative colitis. Moderately Positive Patients with mildly to moderately active ulcerative colitis treated with A. paniculata extract (HMPL-004) at a dose of 1,800 mg daily were more likely to achieve clinical response than those receiving placebo.

Chiretta for Immunity

3 studies Moderately Positive It is concluded that Andrographis paniculata had a high degree of effectiveness in reducing the prevalence and intensity of the symptoms in uncomplicated common cold beginning at day two of treatment. No adverse effects were observed or reported. Moderately Positive The baseline characteristics of the patients among the three groups were not different. The efficacy of paracetamol or high dose Andrographis paniculata was significantly more than that of low dose Andrographis paniculata at day 3 in terms of the relief of fever and sore throat. The clinical effects were not different at day 7. Minimal and self limiting side effects were found in about 20 per cent in each group. Slightly Positive The findings of this study revealed that KalmCold was effective in reducing symptoms of upper respiratory tract infection.

Chiretta for Joint support

1 study Slightly Positive Moreover, it was associated to a reduction of rheumatoid factor, IgA, and C4. These findings suggest that A. paniculata could be a useful "natural complement" in the treatment of AR; however, a larger trial and a more extended period of treatment is necessary in order to corroborate these results.

Chiretta for Detox

1 study Slightly Negative A significant rise in the mean CD4(+) lymphocyte level of HIV subjects occurred after administration of 10 mg/kg andrographolide (from a baseline of 405 cells/mm(3) to 501 cells/mm(3); p = 0.002). There were no statistically significant changes in mean plasma HIV-1 RNA levels throughout the trial. Andrographolide may inhibit HIV-induced cell cycle dysregulation, leading to a rise in CD4(+) lymphocyte levels in HIV-1 infected individuals.

What are Chiretta's effects on the body?

Chiretta for the Immune System

2 studies It is concluded that Andrographis paniculata had a high degree of effectiveness in reducing the prevalence and intensity of the symptoms in uncomplicated common cold beginning at day two of treatment. No adverse effects were observed or reported. The baseline characteristics of the patients among the three groups were not different. The efficacy of paracetamol or high dose Andrographis paniculata was significantly more than that of low dose Andrographis paniculata at day 3 in terms of the relief of fever and sore throat. The clinical effects were not different at day 7. Minimal and self limiting side effects were found in about 20 per cent in each group.

Chiretta for the Digestive System

3 studies HMPL-004 may be an efficacious alternative to mesalazine in ulcerative colitis. Patients with mildly to moderately active ulcerative colitis treated with A. paniculata extract (HMPL-004) at a dose of 1,800 mg daily were more likely to achieve clinical response than those receiving placebo. A significant rise in the mean CD4(+) lymphocyte level of HIV subjects occurred after administration of 10 mg/kg andrographolide (from a baseline of 405 cells/mm(3) to 501 cells/mm(3); p = 0.002). There were no statistically significant changes in mean plasma HIV-1 RNA levels throughout the trial. Andrographolide may inhibit HIV-induced cell cycle dysregulation, leading to a rise in CD4(+) lymphocyte levels in HIV-1 infected individuals.

Chiretta for the Skeletal System

1 study Moreover, it was associated to a reduction of rheumatoid factor, IgA, and C4. These findings suggest that A. paniculata could be a useful "natural complement" in the treatment of AR; however, a larger trial and a more extended period of treatment is necessary in order to corroborate these results.

Chiretta for the Respiratory System

1 study The findings of this study revealed that KalmCold was effective in reducing symptoms of upper respiratory tract infection.